Newark, NJ (PressExposure) October 15, 2012 -- MakroCare, an International Development and Commercialization services firm that is dedicated to support Life Sciences industry will be exhibiting at RAPS 2012 in Seattle, USA.
The Regulatory Affairs Professionals Society (RAPS), an international organization of regulatory professionals is hosting 2012 RAPS Annual Conference on "The Regulatory Convergence" in Seattle, U.S from October 26-30, 2012. This is a unique conference and a place to connect more than 2000 regulatory professionals and thought leaders of the industry, government and academia.
The event is the largest annual gathering for regulatory professionals from around the world working for pharmaceutical, biotechnology, medical device and other related companies; regulators; researchers; academics and others involved in the regulation of healthcare and related products.
In this conference speakers will update attendees on the latest developments in healthcare product regulation. Among the topics expected to draw particular interest are the FDA user fee programs established by the Food and Drug Administration Safety and Innovation Act (FDASIA) passed earlier this year.
Other topics of interest will include the regulatory pathways for biosimilars among different global authorities; regulation of mobile apps, social media and software; global regulatory cooperation and harmonization; pharmaceutical advertising and promotion; new frontiers in vaccines; regulation of health-related foods; revisions to FDA's 510(k) clearance process for medical devices; regulatory issues in clinical trials and clinical evaluation of medical devices; recalls and public access to safety information.
MakroCare is sponsoring and exhibiting at Booth No 314, Visitors/Delegates are welcome to visit our booth to know more about our company and services in the Regulatory space.
More About MakroCare:
MakroCare is an international drug development and commercialization services firm that is dedicated to efficient, high-level performance in combination with unparalleled client satisfaction supporting from USA, Europe and Asia. MakroCare has 5 subsidiaries/divisions Consulting, CRO, SMO, DDi and Commercialization. MakroCare has teams positioned worldwide in these divisions supporting product life cycle management, regulatory affairs, risk management, regulatory compliance, trial management (clinical, late phase), monitoring, biometrics (CDM, EDC, Biostat, SAS programming), Medical Writing (Regulatory, Clinical), QA audits, Drug safety / Pharmacovigilance, Site management, Patient Recruitment, Informatics (EDC, CTMS, IVRS), Commercialization, and Marketing/Sales.